Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03058003 · ClinicalTrials.gov registry record

Correlation Between Central Sensitization Inventory and Posturographic Data

A clinical trial of Central Nervous System Sensitization, sponsored by Caps Research Network.

Completed
Registry status
180
Enrollment target
2
Study locations

NCT03058003 is a study of Central Nervous System Sensitization that has completed, run by Caps Research Network. The registered enrollment target is 180 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03058003, a study of Central Nervous System Sensitization, has completed, sponsored by Caps Research Network.

COMPLETED
Registry status
180 participants
Enrollment target
2
Study locations

Study Summary

To investigate the use of balance as a screening tool for Central Sensitization, a condition of the nervous system that is associated with the development and maintenance of chronic pain. This is done by comparing the scores of a gold standard screening tool (the Central Sensitization Inventory) with balance data.

Interventions

  • DIAGNOSTIC_TEST Posturography Evaluation
  • OTHER Central Sensitization Inventory

Study Locations (2)

Georgia

  • Innova Brain Rehabilitation - Marietta

Victoria

  • Small Street Clinic - Hampton

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2016-05
Est. Completion 2021-04

Sponsor

Caps Research Network

3 total trials

What the Registry Record Tells You About NCT03058003

The ClinicalTrials.gov registry entry for NCT03058003 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Caps Research Network, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Central Nervous System Sensitization appearing as the primary indexed condition, and to 2 interventions - of which Posturography Evaluation is the first listed.

NCT03058003 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Victoria.

Frequently Asked Questions

What is clinical trial NCT03058003 about?

NCT03058003 is a clinical study titled "Correlation Between Central Sensitization Inventory and Posturographic Data". To investigate the use of balance as a screening tool for Central Sensitization, a condition of the nervous system that is associated with the development and maintenance of chronic pain. This is done by comparing the scores of a gold standard screening tool (the Central Sensitization Inventory) wit...

What is the current status of trial NCT03058003?

This trial is currently completed. The enrollment target is 180 participants. The study started on 2016-05. Estimated completion is 2021-04.

What conditions does trial NCT03058003 study?

This clinical trial studies the following conditions: Central Nervous System Sensitization.

What interventions are being tested in trial NCT03058003?

The interventions under investigation include: Posturography Evaluation (DIAGNOSTIC_TEST), Central Sensitization Inventory (OTHER).

Who is sponsoring clinical trial NCT03058003?

This trial is sponsored by Caps Research Network, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03058003 being conducted?

This trial has 2 study locations across Georgia, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.